Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RHODENNA SUE ARN

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1700259199
CMS profile
11091822
Location
GASTONIA, NC

General Payments · PY2021–2024

$1,157.33

  • Reported across 40 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$631.31

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $631.31 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $27.77 2
PY2022 $150.17 8
PY2023 $348.08 14
PY2024 $631.31 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $31.04 02/07/2024 Food and Beverage Undisputed 01/23/2026 1078897285 CMS
ANI Pharmaceuticals, Inc. $15.86 08/27/2024 Food and Beverage Undisputed 01/23/2026 1091158640 CMS
AstraZeneca Pharmaceuticals LP $22.24 01/31/2024 Food and Beverage Undisputed 01/23/2026 1105784780 CMS
GlaxoSmithKline, LLC. $15.19 06/05/2024 Food and Beverage Undisputed 01/23/2026 1116651623 CMS
GlaxoSmithKline, LLC. $16.42 07/15/2024 Food and Beverage Undisputed 01/23/2026 1116214443 CMS
Insmed, Inc. $22.00 03/20/2024 Food and Beverage Undisputed 01/23/2026 1089575490 CMS
Inspire Medical Systems, Inc. $46.45 02/07/2024 Food and Beverage Undisputed 01/23/2026 1148132123 CMS
Inspire Medical Systems, Inc. $121.59 02/08/2024 Food and Beverage Undisputed 01/23/2026 1148132128 CMS
Inspire Medical Systems, Inc. $23.23 02/08/2024 Food and Beverage Undisputed 01/23/2026 1148132132 CMS
Inspire Medical Systems, Inc. $6.63 02/08/2024 Food and Beverage Undisputed 01/23/2026 1148132136 CMS
Inspire Medical Systems, Inc. $83.90 02/09/2024 Food and Beverage Undisputed 01/23/2026 1148132141 CMS
Inspire Medical Systems, Inc. $6.90 02/27/2024 Food and Beverage Undisputed 01/23/2026 1148132145 CMS
Inspire Medical Systems, Inc. $105.60 05/22/2024 Food and Beverage Undisputed 01/23/2026 1148132149 CMS
PFIZER INC. $22.19 04/24/2024 Food and Beverage Undisputed 01/23/2026 1131334318 CMS
Pulmonx Corporation $67.52 09/13/2024 Food and Beverage Undisputed 01/23/2026 1087852134 CMS
Tactile Systems Technology Inc $24.55 08/07/2024 Food and Beverage Undisputed 01/23/2026 1082372131 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.